cefmenoxime was somewhat less active than moxalactam or ceftizoxime against enterobacter cloacae , enterobacter aerogenes , and enterobacter agglomerans , but was more active than cefotaxime , ceftizoxime , or ceftazidime against morganella ( minimum inhibitory concentration for 90 % of isolates , 0.1 microgram/ml . ) , proteus vulgaris and providencia spp .
C0007549
cefmenoxime
C0007554
cefotaxime